Keyphrases
Chronic Kidney Disease
100%
Renal Fibrosis
100%
Calcitriol
100%
Renin-angiotensin-aldosterone System
100%
Paricalcitol
100%
Renal Inflammation
75%
MRNA Level
50%
Renal Interstitial Fibrosis
50%
System Inflammation
50%
Leukocytes
25%
Angiotensin II Type 1 Receptor (AT1R)
25%
Transforming Growth Factor-β
25%
End-stage Renal Disease
25%
Antifibrotic
25%
Inhibitory Action
25%
Treatment Effect
25%
E-cadherin
25%
Secondary Hyperparathyroidism
25%
Epithelial-mesenchymal Transition
25%
Inflammatory Fibrosis
25%
Collagen I
25%
Vitamin D Receptor
25%
Interstitial Fibrosis
25%
Nephrectomy
25%
Dose Ratio
25%
CD45
25%
Equivalent Dose
25%
Renin-angiotensin
25%
Renal Interstitial
25%
Renal Changes
25%
Metaloproteinases
25%
ATR2
25%
Medicine and Dentistry
Calcitriol
100%
Kidney Fibrosis
100%
Paricalcitol
100%
Chronic Kidney Disease
75%
Idiopathic Pulmonary Fibrosis
75%
Nephritic Syndrome
75%
Messenger RNA
75%
Biological Marker
25%
Leukocyte
25%
End Stage Renal Disease
25%
Uvomorulin
25%
Nephrectomy
25%
Transforming Growth Factor Beta
25%
Secondary Hyperparathyroidism
25%
Mesenchymal-Epithelial Transition
25%
Equivalent Dose
25%
Angiotensin Receptor
25%
Vitamin D Receptor
25%
Experimental Chronic Renal Failure
25%
Renin-Angiotensin
25%
Pharmacology, Toxicology and Pharmaceutical Science
Calcitriol
100%
Kidney Fibrosis
100%
Paricalcitol
100%
Chronic Kidney Failure
75%
Fibrosing Alveolitis
75%
Nephritis
75%
Messenger RNA
75%
Biological Marker
25%
Renin
25%
Inflammation
25%
End Stage Renal Disease
25%
Secondary Hyperparathyroidism
25%
Vitamin D Receptor
25%
Uvomorulin
25%
Transforming Growth Factor Beta
25%
Angiotensin 1 Receptor
25%
Experimental Chronic Renal Failure
25%